KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress
KORU Medical Systems, Inc. (KRMD) Q1 2026 Earnings Call Transcript
KORU Medical Systems, Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates
KORU Medical Systems Announces First Quarter 2026 Results
KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026
KORU Medical Systems, Inc. $KRMD Shares Bought by Acuitas Investments LLC
KORU Medical Secures EU MDR Certification for Freedom60 Infusion Pump
KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility
KORU Medical Systems, Inc. (KRMD) Q4 2025 Earnings Call Transcript
KORU Medical Systems, Inc. (KRMD) Reports Q4 Loss, Beats Revenue Estimates
KORU Medical Systems Announces CEO Transition
KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance
Brokerages Set KORU Medical Systems, Inc. (NASDAQ:KRMD) Price Target at $6.13
Down 18.1% in 4 Weeks, Here's Why KORU Medical Systems, Inc. (KRMD) Looks Ripe for a Turnaround
Analyzing KORU Medical Systems (NASDAQ:KRMD) and Outset Medical (NASDAQ:OM)
KORU Medical Systems, Inc. (NASDAQ:KRMD) Receives $6.13 Average PT from Analysts
KORU Medical Systems, Inc. (KRMD) Soars 5.6%: Is Further Upside Left in the Stock?
Acuitas Investments LLC Reduces Position in KORU Medical Systems, Inc. $KRMD
KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System
All You Need to Know About KORU Medical Systems, Inc. (KRMD) Rating Upgrade to Buy
Head to Head Analysis: Patient Portal Technologies (OTCMKTS:PPRG) & KORU Medical Systems (NASDAQ:KRMD)
KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow
3 MedTech Stocks That Crushed the S&P 500 Over the Past Year
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
KRMD Submits 510(k) to Use FreedomEDGE System With Oncology Biologic
Analyzing Movano (NASDAQ:MOVE) and KORU Medical Systems (NASDAQ:KRMD)
KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic
Albion Financial Group UT Sells 140,000 Shares of KORU Medical Systems, Inc. $KRMD
KORU Medical Systems (NASDAQ:KRMD) & P3 Health Partners (NASDAQ:PIII) Head to Head Survey
KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer
Head to Head Review: KORU Medical Systems (NASDAQ:KRMD) and Veeva Systems (NYSE:VEEV)
KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025
KORU Medical Systems to Participate in Upcoming Investor Conferences
KORU Medical Systems, Inc. (KRMD) Q3 2025 Earnings Call Transcript
KORU Medical Systems, Inc. (KRMD) Reports Q3 Loss, Tops Revenue Estimates
KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance
KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems
KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025
ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy
Cirtec Medical Announces Appointment of New Chief Executive Officer
KORU Medical Systems, Inc. (KRMD) Q2 2025 Earnings Call Transcript
KORU Medical Systems, Inc. (KRMD) Reports Break-Even Earnings for Q2
KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference
KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025
KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer
KORU Medical Systems to Join Russell 3000® and Russell 2000® Indexes
KORU Medical Systems, Inc. (KRMD) Q1 2025 Earnings Call Transcript